Looking for a Lexapro attorney in Washington, DC? Get in touch with one of our Lexapro attorneys in Washington, DC now.
Lexapro - News Articles
-
May 27, 2008
Journal of American Medical Association (subscription), IL -
The authors report that patients who received escitalopram or problem-solving therapy had a significantly lower risk of depression in the 12 months ... -
May 12, 2008
DG News -
By Charlene Laino WASHINGTON, DC -- May 12, 2008 -- Treatment with escitalopram oxalate appears to result in clinically meaningful improvements in adolescent patients with depression, suggest results of a phase 3, randomized, double-blind, placebo-controlled trial. ... -
May 16, 2008
domain-B, India -
Mumbai: Ahmedabad-based pharma company, Zydus Cadila has received approval from the United States Food and Drug Agency (USFDA) to market the anti-cholestrol pravastatin sodium in tablet form in the US. The Indian pharma major has also received a tentative ... -
May 15, 2008
Myiris.com, India -
Zydus Cadila has received four products approval from the USFDA. The group has received approval to market Pravastatin sodium tablets USP and tentative approvals for Escitalopram Oxalate tablets, Losartan potassium and Hydrochlorothiazide tablets and Anastrazole tablets. The US market of Pravastatin ... -
May 15, 2008
TopNews, India -
Cadila Healthcare Ltd has announced that its Zydus Cadila unit has received four products approval from the US Food and Drug Administration. The group has got nod to promote Pravastatin sodium tabs USP 10, 20, 40 and 80 mg, ... -
May 15, 2008
TopNews, India -
Pharmaceutical major Zydus Cadila has informed that the company has received four product approvals from the United States Food and Drug Agency (USFDA). The company has received approvals to market Pravastatin Sodium Tablets USP in 10, 20, 40 and 80 mg ... -
May 14, 2008
Business Standard, India -
Ahmedabad-based Zydus Cadila has received four product approvals from the United States Food and Drug Agency (USFDA), the company said in a communication to the Bombay Stock Exchange. google_ad_client = ... -
May 14, 2008
Reuters India, India -
MUMBAI (Reuters) - Cadila Healthcare Ltd said on Thursday its Zydus Cadila unit had received tentative approval from the US Food and Drug Administration to sell escitalopram oxalate tablets and anastrazole tablets. ... -
May 15, 2008
Economic Times, India -
15 May, 2008, 1433 hrs IST, PTI MUMBAI: Pharma major Zydus Cadila on Thursday said it has received approval from the US FDA to market four products, including anti-depressant Escitalopram Oxalate tablets in that country. The ... -
May 15, 2008
Forbes, NY -
MUMBAI (Thomson Financial) - Indian pharmaceuticals company Zydus Cadila said it received four product approvals from the US Food and Drug Administration with a market size of $6.498 billion. The market size of pravastatin sodium ...
-
May 15, 2008
NDTV.com, India -
PTI The US Food and Drug Administration has granted approval to four drugs manufactured by the Gujarat-based pharmaceutical Zydus Cadilla. Announcing this Thursday, the company said authorities in the US had given the green signal to ... -
May 12, 2008
WELT ONLINE, Germany -
Sepracor Inc. (Nasdaq: SEPR) today announced the publication of a study of LUNESTA tablets in patients with insomnia and co-morbid generalized anxiety ... -
May 28, 2008
NBC 11.com, CA -
CHICAGO -- New research suggests doctors may want to give stroke victims antidepressants right away instead of waiting until they develop depression, which is a common complication. The study, appearing in the Journal of the American Medical Association, may lead ... -
May 27, 2008
Newswise (press release) -
Newswise — University of Iowa researchers have shown for the first time that an anti-depressant and a form of talk therapy each can prevent or delay the onset of depression in people who have had acute stroke. The findings will appear in the May ... -
May 27, 2008
Insider Medicine, Canada -
(May 27, 2008 - Insidermedicine) Treatment with an antidepressant drug or participation in problem-solving therapy can help reduce the risk of developing depression in the year following a stroke, according to research published in the Journal of the American Medical Association. ... -
May 28, 2008
Iowa City Press Citizen, IA -
About 700000 Americans suffer a stroke every year, and 40 percent to 50 percent of those patients develop depression, according to the American Stroke Association. This psychological disorder can have a negative impact on recovery time, quality of life and life expectancy. ... -
May 28, 2008
DesMoinesRegister.com, IA -
By MASON KERNS • Register Iowa City Bureau • May 28, 2008 Iowa City, Ia. — Patients recovering from stroke could benefit from medication and verbal therapy to prevent depression, a University of Iowa study to be published today indicates. The study, to be published ... -
May 28, 2008
RedOrbit, TX -
By Marilyn Elias Preventive use of antidepressants slashes the depression rate of stroke patients by more than half and could help them live years longer, ... -
May 28, 2008
Radio Iowa, IA -
By Matt Kelley A University of Iowa study finds stroke victims who are given anti-depression medication and "talk therapy" are much more likely to avoid depression and live longer, happier lives. Dr. Robert Robinson, a professor and head of psychiatry at the U-of-I College ... -
May 27, 2008
The Associated Press -
CHICAGO (AP) — Doctors may want to give stroke victims antidepressants right away instead of waiting until they develop depression, a common complication, new research suggests. The findings may lead to an expanded use for antidepressants. Someday high-risk people like stroke ...
Looking for a Lexapro attorney in Washington, DC? Get in touch with one of our Lexapro attorneys in Washington, DC now.
Pages: 1 2 3 4 5 6 ... Next
